Display options
Share it on

Clin Ophthalmol. 2014;8:143-8. doi: 10.2147/OPTH.S56483. Epub 2013 Dec 27.

Retinal angiomatous proliferation associated with risk alleles of ARMS2/HTRA1 gene polymorphisms in Japanese patients.

Clinical ophthalmology (Auckland, N.Z.)

Yasuhiro Ohkuma, Takaaki Hayashi, Tsutomu Sakai, Akira Watanabe, Hisashi Yamada, Masakazu Akahori, Takeshi Itabashi, Takeshi Iwata, Toru Noda, Hiroshi Tsuneoka

Affiliations

  1. Department of Ophthalmology, Tokyo, Japan.
  2. Department of Molecular Genetics, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  3. Division of Molecular and Cellular Biology, National Institute of Sensory Organs, Tokyo, Japan.
  4. Division of Ophthalmology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

PMID: 24403817 PMCID: PMC3883616 DOI: 10.2147/OPTH.S56483

Abstract

BACKGROUND: The purpose of this study was to investigate the association between ARMS2/HTRA1, CFH, and C3 gene polymorphisms and retinal angiomatous proliferation (RAP), an infrequent and severe form of exudative age-related macular degeneration, which is characterized by intraretinal neovascularization.

METHODS: Diagnosis of RAP was based on fundus photographs, images of fluorescein and indocyanine green angiographies, and optical coherence tomography findings. Six single nucleotide polymorphisms (SNPs), A69S (rs10490924) in ARMS2, rs11200638 in HTRA1, I62V (rs800292) in CFH, Y402H (rs1061170) in CFH, R80G (rs2230199) in C3, and rs2241394 in C3, were genotyped in eight Japanese patients with RAP.

RESULTS: The two SNPs in the ARMS2/HTRA1 were in complete linkage disequilibrium. The frequency of the risk T allele in ARMS2 (the risk A allele in HTRA1) was 93.8% in the RAP patients. The frequency of homozygosity for the risk genotype TT of ARMS2 (the risk genotype AA of HTRA1) was 87.5%. The frequency of the non-risk allele (A) of I62V was 100%. The frequencies of risk alleles of Y402H, R80G, and rs2241394 were 12.5%, 0%, and 18.8%, respectively.

CONCLUSION: Our results suggest that the risk alleles of the ARMS2/HTRA1 SNPs may be associated with development of RAP and play a major role in the pathogenesis of intraretinal angiogenesis.

Keywords: ARMS2/HTRA1 genes; age-related macular degeneration; components of the complement system; retinal angiomatous proliferation; single nucleotide polymorphisms

References

  1. Ophthalmology. 2000 Apr;107(4):742-53; discussion 753-4 - PubMed
  2. Br J Ophthalmol. 2007 Mar;91(3):354-9 - PubMed
  3. Am J Ophthalmol. 2004 Mar;137(3):486-95 - PubMed
  4. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3312-7 - PubMed
  5. Retina. 2009 Jun;29(6):732-9 - PubMed
  6. Br J Ophthalmol. 2001 Oct;85(10):1153-7 - PubMed
  7. Mol Vis. 2006 Dec 05;12:1536-42 - PubMed
  8. Nat Genet. 2006 Sep;38(9):1049-54 - PubMed
  9. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5315-9 - PubMed
  10. Science. 2005 Apr 15;308(5720):421-4 - PubMed
  11. Retina. 2007 Feb;27(2):198-203 - PubMed
  12. Retina. 2014 Feb;34(2):321-9 - PubMed
  13. Nat Genet. 2006 Sep;38(9):1055-9 - PubMed
  14. Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16227-32 - PubMed
  15. Nat Genet. 2008 Jul;40(7):892-6 - PubMed
  16. Science. 2005 Apr 15;308(5720):419-21 - PubMed
  17. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5914-9 - PubMed
  18. Ophthalmology. 2009 Nov;116(11):2135-40 - PubMed
  19. Nat Genet. 2006 Oct;38(10):1173-7 - PubMed
  20. Ophthalmology. 1991 Jul;98(7):1128-34 - PubMed
  21. Science. 2005 Apr 15;308(5720):385-9 - PubMed
  22. Arch Ophthalmol. 2005 Dec;123(12):1644-50 - PubMed
  23. Curr Eye Res. 2009 Aug;34(8):615-22 - PubMed
  24. Am J Ophthalmol. 1994 Sep 15;118(3):285-98 - PubMed
  25. Am J Ophthalmol. 2007 Jul;144(1):15-22 - PubMed
  26. Retina. 2008 Feb;28(2):201-11 - PubMed
  27. N Engl J Med. 2006 Oct 5;355(14):1474-85 - PubMed
  28. Am J Ophthalmol. 2005 May;139(5):917-8 - PubMed
  29. Am J Ophthalmol. 2004 Dec;138(6):1077-9 - PubMed
  30. Invest Ophthalmol Vis Sci. 2008 May;49(5):2071-6 - PubMed
  31. Am J Ophthalmol. 2013 Dec;156(6):1184-1191.e2 - PubMed
  32. Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1131-9 - PubMed
  33. Science. 2006 Nov 10;314(5801):992-3 - PubMed
  34. Mol Vis. 2011;17:2751-8 - PubMed
  35. Hum Mol Genet. 2008 Jun 15;17(12):1821-4 - PubMed
  36. PLoS One. 2008;3(11):e3813 - PubMed
  37. Am J Ophthalmol. 2013 Feb;155(2):260-269.e2 - PubMed
  38. Retina. 2001;21(5):416-34 - PubMed
  39. Exp Eye Res. 2001 Dec;73(6):887-96 - PubMed
  40. J Ocul Biol Dis Infor. 2009 Dec 22;2(4):164-175 - PubMed
  41. Br J Ophthalmol. 2007 Sep;91(9):1173-6 - PubMed
  42. Am J Ophthalmol. 2012 Mar;153(3):530-5 - PubMed
  43. Ophthalmology. 2007 Apr;114(4):738-42 - PubMed
  44. Science. 2006 Nov 10;314(5801):989-92 - PubMed
  45. Ophthalmology. 2009 Feb;116(2):304-10 - PubMed
  46. Retina. 2003 Jun;23(3):417-20 - PubMed
  47. FASEB J. 2000 May;14(7):835-46 - PubMed
  48. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2613-9 - PubMed

Publication Types